Cigna Group — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2020-02-27

Reporting Person: Miller Steven B (EVP, Chief Clinical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-27	Common Stock, $.01 Par Value	F	149.0000	$185.7600	Disposed	26210.0000	Direct
2020-02-28	Common Stock, $.01 Par Value	A	2178.0000	$0.0000	Acquired	28388.0000	Direct
2020-02-28	Common Stock, $.01 Par Value	F	858.0000	$179.4100	Disposed	27530.0000	Direct
2020-02-28	Common Stock, $.01 Par Value	F	1426.0000	$182.9400	Disposed	26104.0000	Direct

Footnotes

F1: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

F2: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

F3: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

F4: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.